- Article
Efficacy of Switching to Adalimumab for Maintenance of Remission Following Induction Therapy with Tacrolimus in Patients with Ulcerative Colitis
- Keijiro Numa,
- Kazuki Kakimoto,
- Yasuyoshi Tanaka,
- Noboru Mizuta,
- Naohiko Kinoshita,
- Kei Nakazawa,
- Ryoji Koshiba,
- Yuki Hirata,
- Kazuhiro Ota and
- Takako Miyazaki
- + 3 authors
Background: Tacrolimus (TAC) effectively induces remission in refractory ulcerative colitis (UC). However, TAC therapy usually lasts for 3 months. Although azathioprine (AZA) is often used in maintenance therapy, the relapse rate remains high. Herein...

